Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Sell
9,396
-429
-4% -$95.2K 0.46% 58
2025
Q4
$2.24M Buy
9,825
+50
+0.5% +$11.4K 0.49% 54
2025
Q3
$2.26M Buy
9,775
+301
+3% +$61.3K 0.49% 54
2025
Q2
$1.76M Sell
9,474
-375
-4% -$69.7K 0.42% 58
2025
Q1
$2.06M Sell
9,849
-1,800
-15% -$350K 0.49% 52
2024
Q4
$2.07M Buy
+11,649
New +$2.14M 0.45% 53

Other funds holding ABBV

one8zero8 LLC's ABBV Position: Q1 2026 in Review

one8zero8 LLC reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $95.2K and leaving 9,396 shares worth $2.04M. The position accounts for 0.46% of the portfolio, ranked #58.

one8zero8 LLC first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.26M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • one8zero8 LLC held 9,396 shares of AbbVie worth $2.04M as of Q1 2026.
  • one8zero8 LLC sold 429 AbbVie shares in Q1 2026, an estimated $95.2K.
  • AbbVie made up 0.46% of one8zero8 LLC's portfolio in Q1 2026, its #58 holding.
  • one8zero8 LLC first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • one8zero8 LLC's AbbVie position peaked at $2.26M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on one8zero8 LLC's 13F filing for Q1 2026, filed 7 May 2026.